News from the FDA/CDC
FDA/CDC
FDA okays first sublingual med for agitation in serious mental illness
With a demonstrated onset of action as early as 20 minutes, dexmedetomidine shows a high response rate in patients at both 120-mcg and 180-mcg...
News from the FDA/CDC
As FDA OKs another COVID booster, some experts question need
“Is the goal to prevent any symptomatic infection with COVID-19, is the goal to prevent the spread of COVID-19, or is the goal to prevent severe...
News from the FDA/CDC
Clozapine interrupted: APA, others seek FDA forum on REMS
Clozapine can decrease the neutrophil count, which can lead to severe neutropenia, serious infection, and death.
News from the FDA/CDC
CDC to update mask recommendations as Omicron spreads
“The best mask that you wear is the one you will wear and the one you can keep on all day long,” said Dr. Rochelle Walensky.
News from the FDA/CDC
FDA OKs new adult insomnia med
Whereas the overall results are very positive, the improvements in daytime functioning are especially “exciting.”
News from the FDA/CDC
CDC defends new COVID guidance as doctors raise concerns
“The new recommendations on quarantine and isolation are not only confusing, but are risking further spread of the virus.”
News from the FDA/CDC
COVID-19–positive or exposed? What to do next
News from the FDA/CDC
COVID-19 antigen tests may be less sensitive to Omicron: FDA
News from the FDA/CDC
FDA authorizes Pfizer antiviral pill for COVID-19
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
Latest News
First Omicron variant case identified in U.S.
“All close contacts have been contacted and have tested negative.”